← Eichor
Study identifier: NCT06989814 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Smart Measurement of Circulating Tumor DNA

Condition: Colorectal Neoplasms · Colorectal Neoplasms Malignant · Colorectal Neoplasms, Hereditary Nonpolyposis  ·  Sponsor: Erasmus Medical Center

PhaseNA
Planned participants50
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this study is to develop a blood-test which can detect colorectal cancer in early stages. Participants will be asked to take an extra blood test, which will be analyzed further in the lab.

This description comes directly from the study's public registry record.

Talk to the study team

Lotte van Leeuwen, BSc  ·  +31646245198  ·  l.vanleeuwen@erasmusmc.nl

Always discuss trial participation with your own doctor first.

Locations (2)

Leiden University Medical CenterLeiden, South Holland, NetherlandsNot Yet Recruiting
Erasmus MCRotterdam, South Holland, NetherlandsRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06989814